Mark Kirschbaum - Net Worth and Insider Trading

Mark Kirschbaum Insider Ownership Reports

Based on ownership reports from SEC filings, as the reporting owner, Mark Kirschbaum owns 1 companies in total, including Cyclacel Pharmaceuticals Inc (CYCC) .

Click here to see the complete history of Mark Kirschbaum’s form 4 insider trades.

Insider Ownership Summary of Mark Kirschbaum

Ticker Comapny Transaction Date Type of Owner
CYCC Cyclacel Pharmaceuticals Inc 2020-10-23 Chief Medical Officer

Mark Kirschbaum Trading Performance

Please note GuruFocus will not track the insiders’ transaction performance if he/she does not have buying transactions.

Mark Kirschbaum Ownership Network

Ownership Network List of Mark Kirschbaum

No Data

Ownership Network Relation of Mark Kirschbaum

Insider Network Chart

Mark Kirschbaum Owned Company Details

What does Cyclacel Pharmaceuticals Inc do?

Who are the key executives at Cyclacel Pharmaceuticals Inc?

Mark Kirschbaum is the Chief Medical Officer of Cyclacel Pharmaceuticals Inc. Other key executives at Cyclacel Pharmaceuticals Inc include director & President & C.E.O. Spiro Rombotis , director & E.V.P. & Finance & C.O.O. Paul Mcbarron , and 10 percent owner Eastern Capital Ltd .

Cyclacel Pharmaceuticals Inc (CYCC) Insider Trades Summary

Over the past 18 months, Mark Kirschbaum made no insider transaction in Cyclacel Pharmaceuticals Inc (CYCC). Other recent insider transactions involving Cyclacel Pharmaceuticals Inc (CYCC) include a net purchase of 6,070 shares made by Spiro Rombotis , and a net purchase of 1,886 shares made by Paul Mcbarron .

In summary, during the past 3 months, insiders sold 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) in total and bought 0 shares, with a net sale of 0 shares. During the past 18 months, 0 shares of Cyclacel Pharmaceuticals Inc (CYCC) were sold and 7,956 shares were bought by its insiders, resulting in a net purchase of 7,956 shares.

Cyclacel Pharmaceuticals Inc (CYCC)'s detailed insider trading history can be found in Insider Trading Tracker table.

To

Cyclacel Pharmaceuticals Inc Insider Transactions

No Available Data

Mark Kirschbaum Mailing Address

Above is the net worth, insider trading, and ownership report for Mark Kirschbaum. You might contact Mark Kirschbaum via mailing address: 66 West 38th Street, Apt. 19d, New York Ny 10018.

Discussions on Mark Kirschbaum

No discussions yet.